Scientists in China believe new drug can stop pandemic 'without vaccine'
A Chinese laboratory has been developing a drug it believes has the power to bring the coronavirus pandemic to a halt.
May 19, 2020
0
11590
A Chinese laboratory has been developing a drug it believes has the power to bring the coronavirus pandemic to a halt.
May 19, 2020
0
11590
A novel formulation of the prostate cancer drug abiraterone acetate—currently marketed as Zytiga—will dramatically improve the quality of life for people suffering from prostate cancer, as pre-clinical trials by the University ...
Jun 20, 2020
0
196
Researchers at The University of Texas MD Anderson Cancer Center have discovered a novel immunotherapy combination, targeting checkpoints in both T cells and myeloid suppressor cells, that successfully reprogrammed the tumor ...
Dec 30, 2022
0
124
A therapeutic vaccine can boost antibodies and T cells, helping them infiltrate tumors and fight off human papillomavirus (HPV)-related head and neck cancer. Researchers from the Abramson Cancer Center of the University of ...
Sep 21, 2018
0
448
About 7.5 million Americans suffer from psoriasis, an autoimmune disease that shows up as patches of red, inflamed skin and painful, scaly rashes. Although there are effective treatments for psoriasis, not everyone responds ...
Nov 19, 2021
0
61
Scientists at the University of Birmingham have developed a novel eye drop that rapidly reduces sight-threatening scarring to the surface of the eye.
Dec 21, 2018
0
235
The Therapeutic Goods Administration (TGA) yesterday announced it has provisionally approved AstraZeneca's COVID vaccine for use in Australia.
Feb 17, 2021
0
5
Research led by the Centenary Institute and University of Technology Sydney (UTS) has identified a small RNA molecule called microRNA-21 as a therapeutic target and its inhibition as a potential treatment for chronic obstructive ...
Nov 24, 2021
0
159
Mount Sinai scientists have identified two markers of inflammation that reliably predict the severity of COVID-19 cases and likelihood of survival, providing a foundation for a diagnostic platform and therapeutic targets, ...
Aug 24, 2020
0
320
A new study led by scientists at VCU Massey Cancer Center has shown that an experimental drug known as AZ32 selectively sensitizes brain tumors to radiation and significantly extends the survival of mouse models with human ...
Jun 27, 2018
0
253